1. Management of bilateral head and neck paragangliomas at a single‐institution across four decades.
- Author
-
Bellamkonda, Nikhil, Tooker, Evan L., Naumer, Anne, Buchmann, Luke O., Kohlmann, Wendy, McCrary, Hilary C., Patel, Neil S., and Espahbodi, Mana
- Subjects
CAROTID body ,CRANIAL nerves ,PARAGANGLIOMA ,GENETIC testing ,SURGERY - Abstract
Background: Bilateral head and neck paragangliomas (HNPGLs) require nuanced management to balance tumor control with functional preservation. Methods: All patients seen at a single‐institution for bilateral paraganglioma between 1983 and 2023 were retrospectively reviewed. Demographics, genetic testing results, and tumor characteristics were analyzed and compared to treatment modality and cranial nerve outcomes. Results: There were 49 patients with 116 tumors (90 carotid body tumors [CBTs], 15 vagal paragangliomas [VPs], and 11 jugular paragangliomas [JPs]). Twenty‐six patients had SDH pathologic variants (PV). Surgical management was more commonly utilized in younger patients (OR: 0.97, 95% CI: 0.950–0.992) and for JPs (OR: 9, 95% CI: 1.386–58.443). In surgical cases, CBTs had a lower risk of postoperative cranial nerve deficits compared to JPs and VPs (OR: 0.095, 95% CI: 0.013–0.692). Conclusions: Younger patients with bilateral HNPGLs, especially those with JP and CBT, are more often treated with surgery. CBTs have lowest risk of cranial nerve deficits after surgery. [ABSTRACT FROM AUTHOR]
- Published
- 2025
- Full Text
- View/download PDF